Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next
Twist Bioscience Corp shares jumped roughly 14% to $46.88 in late-morning trading Monday, following the release of record quarterly revenue and an upgraded full-year sales outlook.